Novartis (NVS) Drops 3.5% in a Single Session to $150.55
As seen on the 24/7 Wall St. homepage on October 23, 2026.
A 3.54% slide to $150.55 wipes roughly $10 billion off a $286 billion pharma name that rarely moves this much in a single session. Defensive large-cap drugmakers trading like this is worth a look before the close.
Continue ReadingShow less
Novartis fell from its $156.08 open to around $150.53 in minutes, then held the low $150s for the rest of the afternoon without recovering.
A 3.54% single-session decline at this scale erases roughly $10 billion in market value. Defensive large-cap drugmakers rarely move this much without the market paying close attention.
Sponsored
Twelve Tabs, One Thesis
Your Research Resets Every Morning
The quote page in one tab. Filings in another. A chart you rebuilt from scratch, a transcript you never went back and found, a screener whose settings you will redo next week. Nothing you built yesterday is still there.
AlphaSpace replaces all of it with one screen you arrange yourself. Earnings calendar, estimate versus actual, the call transcript, live news, your own charts, every panel wired to whatever ticker you click. Close the browser and it is all still sitting there tomorrow.
See What a Built View Looks Like →
(Sponsor)
A tight range followed by a vertical drop in two consecutive intervals points to a specific catalyst behind the selling.
For holders, the question is whether the low $150s becomes a new range or a pause before further pressure. For anyone on the sidelines, a move this size in a name known for stability warrants a closer look before the close.
Sources
Mentioned: NVS